medigraphic.com
ISSN 1561-3070 (Electronic)

2021, Number 1

<< Back Next >>

Rev Cub Oftal 2021; 34 (1)

Prevalence of visual impairment among adult diabetics in Cuba

Rodríguez RBN, Río TM, Padilla GCM, Barroso LR, González PA, Fernández ML, Molina SY, Torres GO, Cheon QM, González RL, Molina CC, Nápoles ÁA, Sureda MM, Avila BD

Language: Spanish
References: 35
Page: 1-27
PDF size: 633.99 Kb.


ABSTRACT

Objective: Describe visual impairment among diabetics aged 50 years and over, and the coverage of ophthalmological care in Cuba in the year 2016.
Methods: A descriptive cross-sectional epidemiological study was conducted based on the Rapid Assessment of Avoidable Blindness survey developed in Cuba in the year 2016, which included diabetic retinopathy with validation by the World Health Organization. The data obtained from the questionnaires were transferred to a database of visually impaired known and unknown diabetics.
Results: Prevalence of any sort of visual impairment among diabetics is 25.4% (21.8-28.9). Risk of developing moderate visual impairment, severe visual impairment or blindness is 19.4% (16.5-22.3), 2.8% (1.0-4.6) and 3.2% (1.5-4.8), respectively. Cataract is the leading cause of impairment. Risk of visual impairment among diabetics is similar in the two sexes and increases with age. Treatment coverage is low.
Conclusions: In Cuba, about one fourth of the diabetics are at some risk of visual impairment. Diabetics are at a higher risk of moderate visual impairment. However, the risk of severe visual impairment and blindness is the same as for the population aged 50 years and over. Cataract and diabetic retinopathy are the most common causes of visual impairment among diabetics. Difficulties were found in ophthalmological care, including examination and treatment coverage for cataract and laser therapy for diabetic retinopathy.


REFERENCES

  1. Organización Mundial de la Salud. Salud ocular universal: un plan de acción mundial para 2014-2019. OMS; 2013 [acceso: 12/06/2019]. Disponible en http://www.who.int/publications/list/universal_eye_health/es/

  2. Rodríguez Rodríguez BN. Discapacidad visual en el adulto diabético en cuba [tesis] Instituto Cubano de Oftalmología Ramón Pando Ferrer. La Habana. 2017 [acceso: 12/06/2019]. Disponible en: http://eduniv.mes.cu/index.php?page=13&id=1489&db=1

  3. Barría F. Diabetes mellitus: Una epidemia mundial. Arch Chil Oftalmol. 2008;65(1):63-6.

  4. Cho NH, Shaw JE, Karuranga S, Huang Y, Da Rocha Fernandes JD, Ohlrogge AW, et al. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diab Res Clin Pract. 2018.138:271-81.Doi: http://dx.doi.org/10.1016/j.diabres.2018.02.023

  5. MINSAP. Anuario estadístico 2013, 2014, 2015, 2016, 2017, 2018 y 2019. La Habana: MINSAP; 2019 [acceso: 21/12/2019]. Disponible en: Disponible en: http://www.sld.cu/servicios/estadisticas

  6. Organización Mundial de la Salud. Informe mundial sobre el envejecimiento y la salud. OMS; 2015 [acceso: 21/12/2018]. Disponible en: http://www.who.int

  7. ONEI. Anuario estadístico de Cuba. Población 2016. La Habana: ONEI; 2017 [acceso: 23/12/2019]. Disponible en: Disponible en: http://www.one.cu/aec2016.htm

  8. Barría F, Martínez F, Verdaguer J. Actualización de la guía clínica de retinopatía diabética para Latinoamérica. ICO-PAAO-IAPV; 2016 [acceso: 19/09/2019]. Disponible en: https://issuu.com/japhsion/docs/guia_clinica_rd_paao_ico_16_may_2017

  9. Flaxman SR, Bourne RRA, Resnikoff S, Ackland P, Braithwaite T, Cicinelli MV, et al. Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis. Lancet Glob Health. 2017;5:1221-34. DOI: http://dx.doi.org/10.1016/S2214-109X(17)30393-5

  10. Shah AS, Chen SH. Cataract surgery and diabetes. Curr Opin Ophthalmol. 2010; 21(1):4-9.

  11. Ederer F, Hiller R, Taylor HR. Senile lens changes and diabetes in two population studies. Am J Ophthalmol. 1981;91(3):381-95.

  12. Rodríguez Rodríguez B. Prevención de ceguera por retinopatía diabética en Cuba. ¿Dónde estamos? Rev Cubana Oftalmol. 2015;28(1):119-28.

  13. Hernández Silva J, Río Torres M, Padilla González C. Resultados del RACSS en Ciudad de La Habana, Cuba, 2005. Rev Cubana Oftalmol. 2006;19(1) [acceso: 12/10/2019]. Disponible en: Disponible en: http://scielo.sld.cu/scielo.php?script=sci_abstract&pid=S0864-21762006000100001&lng=es&nrm=iso&tlng=es

  14. MINSAP. Programa nacional de diabetes 2000. La Habana: MINSAP; 2019 [acceso: 12/06/2019]. Disponible en: http://www.sld.cu/galerias/pdf/sitios/diabetes/programa__nacional_de_diabetes.pdf

  15. Kuper H, Polack S, Limburg H. Rapid Assessment of Avoidable Blindness. Comm Eye Health. 2006;19(60):68-9.

  16. Ríos Torres M, Rodríguez Rodríguez BN, Padilla González CM, Barroso Lorenzo R, et al. Encuesta Nacional de ceguera y discapacidad visual en el adulto mayor, 2016. La Habana: Organización Panamericana de la Salud; 2017 [acceso: 22/02/2020]. Disponible en: Disponible en: http://pesquisa.bvsalud.org/portal/resource/pt/biblio-972201

  17. Limburg H, Meester W, Kuper H, Polack S, International Centre for Eye Health. Evaluación rápida de la ceguera evitable. Londres, Reino Unido: London School of Hygiene and Tropical Medicine; 2011 [acceso: 20/05/2019]. Disponible en: Disponible en: https://www.cehjournal.org/resources/raab/

  18. National Diabetes Retinopathy Screening. Scottish Diabetic Retinopathy. Grading Scheme; 2007 [acceso: 20/05/2019]. Disponible en: http://www.ndrs.scot.nhs.uk/Clingrp/Docs/Grading%2520Scheme%25202007%2520v1.1.pdf

  19. Bourne RR, Flaxman SR, Braithwaite T, Cicinelli MV, Das A, Jonas JB, et al. Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: a systematic review and meta-analysis. Lancet Glob Health. 2017;5(9):e888- e97.

  20. Kulkarni S, Kondalkar S, Mactaggart I, et al. Estimating the magnitude of diabetes mellitus and diabetic retinopathy in an older age urban population in Pune, Western India. BMJ Open Ophthalmology. 2019;4:000201.

  21. Kahloun R, Jelliti B, Zaouali S, Attia S, Ben Yahia S, Resnikoff S, Khairallah M. Prevalence and causes of visual impairment in diabetic patients in Tunisia, North Africa. Eye. 2014;28(8):986-91.

  22. Zatic T, Bendelic E, Paduca A, Rabiu M, Corduneanu A, GarabaA, et al. Rapid assessment of avoidable blindness and diabetic retinopathy in Republic of Moldova. Br J Ophthalmol. 2015;99(6):832-36.

  23. Lopez-Ramos A, Gómez-Bastar PA, Lansingh CCh, Rodríguez-Gómez JA, Vargas-Fragoso V, Soria-Arellano FA, et al. Rapid assessment of avoidable blindness: Prevalence of blindness, visual impairment and diabetes in Nuevo León, México. Ophthal Epidemiol. 2018 ;25. DOI: https://doi.org/10.1080/09286586.2018.1501498

  24. López-Star EM, Allison-Eckert K, Limburg H, Brea-Rodríguez I, Lansingh VC. Evaluación rápida de la ceguera evitable, incluida la retinopatía diabética, en Querétaro, México. Rev Mex Oftalmol. 2018;92(2):84-93.

  25. Minderhoud J, Pawiroredjo JC, Bueno de Mesquita-Voigt AM, et al. Diabetes and diabetic retinopathy in people aged 50 years and older in the Republic of Suriname. Br J Ophthalmol. 2016;100(6):814-18.

  26. Tóth G, Szabó D, Sándor GL, et al. Diabetes and diabetic retinopathy in people aged 50 years and older in Hungary. Br J Ophthalmol. 2016;101(7): 965-9.

  27. Polack S, Yorston D, López-Ramos A, Lepe-Orta S, Martin Baia R, Alves L, et al. Rapid assessment of avoidable blindness and diabetic retinopathy in Chiapass, Mexico. Ophthalmology. 2012;119:1033-40.

  28. Yorston DB, Polack S, Kuper H, Cockburn N, Gómez P, Rabiu M. RAAB+DR - Rapid Assessment of Blindness Including Diabetes: Results of a New Population-based Survey Method in Chiapas (Mexico), Cape Town (South Africa) and Taif (Saudi Arabia). Ophthalmol Vis Sci. 2012;53(3):6345.

  29. Al Ghamdi AH, Rabiu M, Hajar S, Yorston D, Kuper H, Polack S. Rapid assessment of avoidable blindness and diabetic retinopathy in Taif, Saudi Arabia. Br J Ophthalmol. 2012;96(9):1168-72.

  30. Hajar S, Al Hazmi A, Wasli M, Mousa A, Rubiu M. Prevalence and causes of blindness and diabetic retinopathy in Southern Saudi Arabia. Saudi Med J. 2015;36(4): 449-55.

  31. Rabiu MM, Al Bdour MD, Abu Ameerh MA, Jadoon MZ. Prevalence of blindness and diabetic retinopathy in Northern Jordan. Eur J Ophthalmol. 2015;25(4):320-7.

  32. Katibeh M, Behboudi H, Moradian S, Alizadeh Y, Beiranvand R, Sabbaghi H, et al. Rapid Assessment of Avoidable Blindness and Diabetic Retinopathy in Gilan Province, Iran. Ophthal Epidemiol. 2017;24(6):381-7.

  33. Al-Ghamdi AS. Adults visual impairment and blindness - An overview of prevalence and causes in Saudi Arabia. Saudi J Ophthalmol. 2019;10. DOI: https://doi.org/10.1016/j.sjopt.2019.10.001

  34. Acevedo Castellón RI, Carranza Vargas E, Cortés Chavarría RE, Rodríguez Vargas GA. Rapid assessment of avoidable blindness and diabetic retinopathy in individuals aged 50 years or older in Costa Rica. PLoS ONE. 2019;14(2):0212660.

  35. Río Torres M. Cirugía de cataratas en Cuba. Rev Cubana Oftalmol. 2019;32(1):710.




2020     |     www.medigraphic.com